vrtx pharmacuticals market cap 2024

On December 31, 2024, Vertex Pharmaceuticals (VRTX) had a market capitalization of $104.9B, based on 260.5M shares at a price of $402.70.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
December 31 2024
$402.70
1,048,120
260,500,000
$104,903,350,000.00
December 30 2024
$399.35
1,455,983
260,500,000
$104,030,675,000.00
December 27 2024
$408.76
1,373,494
260,500,000
$106,481,980,000.00
December 26 2024
$410.65
1,191,539
260,500,000
$106,974,325,000.00
December 24 2024
$408.18
1,468,555
260,500,000
$106,330,890,000.00
December 23 2024
$405.27
2,204,467
260,500,000
$105,572,835,000.00
December 20 2024
$397.27
6,203,131
260,500,000
$103,488,835,000.00
December 19 2024
$396.64
8,208,717
260,500,000
$103,324,720,000.00
December 18 2024
$447.50
1,761,042
260,500,000
$116,573,750,000.00
December 17 2024
$469.24
1,304,829
260,500,000
$122,237,020,000.00
December 16 2024
$468.09
1,511,252
260,500,000
$121,937,445,000.00
December 13 2024
$463.73
1,097,110
260,500,000
$120,801,665,000.00
December 12 2024
$464.12
958,587
260,500,000
$120,903,260,000.00
December 11 2024
$468.29
1,043,840
260,500,000
$121,989,545,000.00
December 10 2024
$469.22
865,214
260,500,000
$122,231,810,000.00
December 09 2024
$473.98
1,260,636
260,500,000
$123,471,790,000.00
December 06 2024
$462.10
1,115,377
260,500,000
$120,377,050,000.00
December 05 2024
$459.92
1,183,850
260,500,000
$119,809,160,000.00
December 04 2024
$463.98
1,220,618
260,500,000
$120,866,790,000.00
December 03 2024
$456.97
1,181,804
260,500,000
$119,040,685,000.00
December 02 2024
$465.73
960,021
260,500,000
$121,322,665,000.00
November 29 2024
$468.13
770,568
260,500,000
$121,947,865,000.00
November 27 2024
$464.56
1,006,928
260,500,000
$121,017,880,000.00
November 26 2024
$467.07
1,327,768
260,500,000
$121,671,735,000.00
November 25 2024
$461.71
2,168,316
260,500,000
$120,275,455,000.00